close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ONCOVITA

News headline image
Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission
From ONCOVITA
Via GlobeNewswire
News headline image
Oncovita presents promising preclinical data on MVdeltaC, a novel onco-immunotherapy at EACR, 8-11 June 2026, in Budapest
From ONCOVITA
Via GlobeNewswire
News headline image
Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new therapeutic candidates from its Measovir® platform.
From ONCOVITA
Via GlobeNewswire
News headline image
Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma
From ONCOVITA
Via GlobeNewswire
News headline image
Oncovita appoints Stéphane Altaba as Chief Executive Officer
From ONCOVITA
Via GlobeNewswire
News headline image
Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology
From ONCOVITA
Via GlobeNewswire
News headline image
Oncovita Won a Financing of €4,5M From Bpifrance and Raised €3,5M From Private Investors and Business Angels
From Oncovita
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.